| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.4M | — | +89.9% |
| Cost of Revenue | $434K | — | +7.7% |
| Gross Profit | $945K | — | +192.6% |
| R&D Expense | $662K | — | -4.2% |
| SG&A Expense | $1.7M | — | +2.6% |
| Operating Income | -$3.3M | — | +10.8% |
| Net Income | -$3.5M | — | +3.9% |
| EPS (Basic) | -$0.31 | — | +69.3% |
| EPS (Diluted) | $0.31 | — | +130.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.6M | +22.7% | -55.3% |
| Accounts Receivable | $2.0M | +16.0% | +122.2% |
| Inventory | $806K | -23.5% | +32.8% |
| Current Assets | $7.6M | +12.6% | -36.4% |
| Total Assets | $12.8M | +19.3% | -4.2% |
| Current Liabilities | $7.4M | +130.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.0M | — | -19.2% |
| Capital Expenditures | $56K | — | — |
| Investing Cash Flow | -$56K | — | — |
| Financing Cash Flow | $3.9M | — | -38.2% |
| Free Cash Flow | -$3.0M | — | — |
| +237.4% |
| Total Liabilities | $10.9M | +91.3% | +172.3% |
| Stockholders' Equity | $1.9M | -62.4% | -79.8% |